Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
In Vitro Pharmacodynamic Effects of Cangrelor in Ticagrelor Treated Patients
NCT02081443Completed
- Sponsor
- University of Florida
- Start
- Apr 2014
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of ticagrelor in coronary artery disease (CAD) (2 arms), sponsored by University of Florida. Primary endpoint: Platelet Reactivity Index Determined by Whole Blood Vasodilator-stimulated Phosphoprotein (VASP). Started Apr 2014; status: completed.
02
Drugs
ticagrelor
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02081443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02081443.